Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 410

1.

Lack of an Association between a Functional Polymorphism in the MDM2 Promoter and Breast Cancer in Women in Northeast Iran.

Tavakkol Afshari Z, Nikpoor AR, Tavakkol Afshari J, Ganjali R, Sanglakh Ghoochan Atigh P, Homaei Shandiz F, Jamialahmadi K.

Rep Biochem Mol Biol. 2017 Oct;6(1):112-117.

2.

The Role of MDM2 in Promoting Genome Stability versus Instability.

Saadatzadeh MR, Elmi AN, Pandya PH, Bijangi-Vishehsaraei K, Ding J, Stamatkin CW, Cohen-Gadol AA, Pollok KE.

Int J Mol Sci. 2017 Oct 23;18(10). pii: E2216. doi: 10.3390/ijms18102216. Review.

3.

Introduction of the MDM2 T309G Mutation in Primary Human Retinal Epithelial Cells Enhances Experimental Proliferative Vitreoretinopathy.

Zhou G, Duan Y, Ma G, Wu W, Hu Z, Chen N, Chee Y, Cui J, Samad A, Matsubara JA, Mukai S, D'Amore PA, Lei H.

Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5361-5367. doi: 10.1167/iovs.17-22045.

4.

New Aspects of Vascular Calcification: Histone Deacetylases and Beyond.

Kwon DH, Kim YK, Kook H.

J Korean Med Sci. 2017 Nov;32(11):1738-1748. doi: 10.3346/jkms.2017.32.11.1738. Review.

5.

Nuclear Envelope Rupture Is Enhanced by Loss of p53 or Rb.

Yang Z, Maciejowski J, de Lange T.

Mol Cancer Res. 2017 Nov;15(11):1579-1586. doi: 10.1158/1541-7786.MCR-17-0084. Epub 2017 Aug 15.

PMID:
28811362
6.

Modulation of the p53 family network by RNA-binding proteins.

Lucchesi C, Zhang J, Chen X.

Transl Cancer Res. 2016 Dec;5(6):676-684. doi: 10.21037/tcr.2016.08.30.

7.

Antitumoral effects of γCdcPLI, a PLA2 inhibitor from Crotalus durissus collilineatus via PI3K/Akt pathway on MDA-MB-231 breast cancer cell.

Gimenes SNC, Lopes DS, Alves PT, Azevedo FVPV, Vecchi L, Goulart LR, Rodrigues TCS, Santos ALQ, Brites VLC, Teixeira TL, da Silva CV, Dias MH, Teixeira SC, Rodrigues RS, Yoneyama KAG, Oliveira RA, Rodrigues VM.

Sci Rep. 2017 Aug 1;7(1):7077. doi: 10.1038/s41598-017-07082-2.

8.

Genome-wide reconstruction of complex structural variants using read clouds.

Spies N, Weng Z, Bishara A, McDaniel J, Catoe D, Zook JM, Salit M, West RB, Batzoglou S, Sidow A.

Nat Methods. 2017 Sep;14(9):915-920. doi: 10.1038/nmeth.4366. Epub 2017 Jul 17.

PMID:
28714986
9.

Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis.

Carr MI, Jones SN.

Transl Cancer Res. 2016 Dec;5(6):707-724. doi: 10.21037/tcr.2016.11.75.

10.

The Role of p16 and MDM2 Gene Polymorphisms in Prolactinoma: MDM2 Gene Polymorphisms May Be Associated with Tumor Shrinkage.

Turgut S, Ilhan M, Turan S, Karaman O, Yaylim I, Kucukhuseyin O, Tasan E.

In Vivo. 2017 May-Jun;31(3):357-363.

11.

NFkB is essential for activin-induced colorectal cancer migration via upregulation of PI3K-MDM2 pathway.

Jana A, Krett NL, Guzman G, Khalid A, Ozden O, Staudacher JJ, Bauer J, Baik SH, Carroll T, Yazici C, Jung B.

Oncotarget. 2017 Jun 6;8(23):37377-37393. doi: 10.18632/oncotarget.16343.

12.

Molecular signature of anastasis for reversal of apoptosis.

Tang HM, Talbot CC Jr, Fung MC, Tang HL.

Version 2. F1000Res. 2017 Jan 13 [revised 2017 Jan 1];6:43. doi: 10.12688/f1000research.10568.2. eCollection 2017.

13.

Interferon-Stimulated Gene 15 in the Control of Cellular Responses to Genotoxic Stress.

Jeon YJ, Park JH, Chung CH.

Mol Cells. 2017 Feb;40(2):83-89. doi: 10.14348/molcells.2017.0027. Epub 2017 Feb 27. Review.

14.

MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk.

Gansmo LB, Bjørnslett M, Halle MK, Salvesen HB, Romundstad P, Hveem K, Vatten L, Dørum A, Lønning PE, Knappskog S.

BMC Cancer. 2017 Feb 3;17(1):97. doi: 10.1186/s12885-017-3094-y.

15.

mir-660-p53-mir-486 Network: A New Key Regulatory Pathway in Lung Tumorigenesis.

Borzi C, Calzolari L, Centonze G, Milione M, Sozzi G, Fortunato O.

Int J Mol Sci. 2017 Jan 23;18(1). pii: E222. doi: 10.3390/ijms18010222.

16.

Dual function of MDM2 and MDMX toward the tumor suppressors p53 and RB.

Hernández-Monge J, Rousset-Roman AB, Medina-Medina I, Olivares-Illana V.

Genes Cancer. 2016 Sep;7(9-10):278-287. doi: 10.18632/genesandcancer.120. Review.

17.

Downregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder.

Lee YY, Wang CT, Huang SK, Wu WJ, Huang CN, Li CC, Chan TC, Liang PI, Hsing CH, Li CF.

J Cancer. 2016 Oct 25;7(15):2187-2196. eCollection 2016.

18.

Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness.

Olivos DJ, Mayo LD.

Int J Mol Sci. 2016 Nov 26;17(12). pii: E1982. Review.

19.

Association of the MDM2 SNP285 Polymorphism with Cancer Susceptibility: A Meta-Analysis.

Wang P, Wang M, Li S, Ma L, Xi S, He J.

Dis Markers. 2016;2016:4585484. Epub 2016 Nov 7. Review.

20.

The Zn-finger domain of MdmX suppresses cancer progression by promoting genome stability in p53-mutant cells.

Matijasevic Z, Krzywicka-Racka A, Sluder G, Gallant J, Jones SN.

Oncogenesis. 2016 Oct 3;5(10):e262. doi: 10.1038/oncsis.2016.62.

Supplemental Content

Support Center